VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 180 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 3.16 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $1,006,000 | -75.1% | 56,200 | -80.5% | 0.07% | -70.3% |
| Q1 2017 | $4,037,000 | -39.6% | 288,392 | -31.1% | 0.22% | -31.3% |
| Q4 2016 | $6,679,000 | -53.0% | 418,732 | -51.0% | 0.32% | -50.5% |
| Q3 2016 | $14,222,000 | +34.6% | 854,656 | -9.5% | 0.65% | +12.0% |
| Q2 2016 | $10,570,000 | +172.1% | 944,568 | +103.3% | 0.58% | +172.0% |
| Q1 2016 | $3,884,000 | -55.4% | 464,568 | -50.3% | 0.21% | -49.4% |
| Q4 2015 | $8,701,000 | -65.6% | 934,568 | -58.3% | 0.42% | -65.3% |
| Q3 2015 | $25,304,000 | -6.9% | 2,243,267 | +4.7% | 1.22% | +14.8% |
| Q2 2015 | $27,180,000 | -12.3% | 2,141,835 | -35.7% | 1.06% | -19.1% |
| Q1 2015 | $30,989,000 | -12.1% | 3,332,189 | +35.4% | 1.31% | -14.2% |
| Q4 2014 | $35,246,000 | +61.3% | 2,461,305 | +16.9% | 1.53% | +56.0% |
| Q3 2014 | $21,852,000 | -36.9% | 2,105,180 | -1.6% | 0.98% | -26.1% |
| Q2 2014 | $34,632,000 | +11.4% | 2,140,400 | +11.8% | 1.33% | -16.4% |
| Q1 2014 | $31,090,000 | +11.9% | 1,913,942 | -14.5% | 1.59% | +24.8% |
| Q4 2013 | $27,780,000 | +103.1% | 2,239,350 | +79.3% | 1.27% | +89.3% |
| Q3 2013 | $13,681,000 | +162.6% | 1,248,650 | +93.3% | 0.67% | +117.5% |
| Q2 2013 | $5,210,000 | – | 645,850 | – | 0.31% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Signpost Capital Advisors, LP | 1,688,952 | $27,327,000 | 10.37% |
| Palo Alto Investors LP | 3,240,424 | $52,430,000 | 3.90% |
| Parametrica Management Ltd | 12,509 | $202,000 | 1.53% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,740,400 | $28,160,000 | 1.08% |
| PACIFIC ALTERNATIVE ASSET MANAGEMENT COMPANY, LLC | 557,100 | $9,014,000 | 1.07% |
| Westend Capital Management, LLC | 64,086 | $841,000 | 1.00% |
| WALL STREET ASSOCIATES | 702,700 | $11,370,000 | 0.98% |
| Baker Brothers Advisors | 4,372,153 | $70,741,000 | 0.87% |
| Iguana Healthcare Management, LLC | 100,000 | $1,618,000 | 0.76% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,085,301 | $17,560,000 | 0.71% |